The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: A need for reappraisal

Virus Research

Volumn 143, Issue 2, 2009, Pages 209-221

  Chang, Cindy M ^a   Yu, Kelly J ^a   Mbulaiteye, Sam M ^a   Hildesheim, Allan ^a   Bhatia, Kishor ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

30 bp deletion; B98 5; BZLF1; EBNA1; EBV; EBV types 1 and 2; Genetic diversity; Genotypes; LMP1; Strain variation; Variants; XhoI loss; Zp

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; IMMEDIATE EARLY PROTEIN BZLF1; LATENT MEMBRANE PROTEIN 1; VIRUS DNA;

AFRICA; AMINO ACID SUBSTITUTION; BURKITT LYMPHOMA; CARCINOGENESIS; CHINA; DISEASE ASSOCIATION; DNA SEQUENCE; EPSTEIN BARR VIRUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHY; HODGKIN DISEASE; INFECTIOUS MONONUCLEOSIS; LEIOMYOSARCOMA; LYMPHOEPITHELIOMA; MEDICAL LITERATURE; NASOPHARYNX CARCINOMA; NK T CELL LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; STOMACH ADENOCARCINOMA; VIRAL GENETICS;

AFRICA; BURKITT LYMPHOMA; CARCINOMA; CHINA; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENETIC VARIATION; GENOTYPE; GEOGRAPHY; HERPESVIRUS 4, HUMAN; HUMANS; NASOPHARYNGEAL NEOPLASMS; TRANS-ACTIVATORS; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 68749117717     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2009.07.005     Document Type: Review

References (160)

1. Abdel-Hamid M., Chen J.J., Constantine N., Massoud M., and Raab-Traub N. EBV strain variation: geographical distribution and relation to disease state. Virology 190 1 (1992) 168-175
2. Aguirre A.J., and Robertson E.S. Characterization of intertypic recombinants of the Epstein-Barr virus from the body-cavity-based lymphomas cell lines BC-1 and BC-2. Virology 264 2 (1999) 359-369
3. Aitken C., Sengupta S.K., Aedes C., Moss D.J., and Sculley T.B. Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus. J. Gen. Virol. 75 Pt 1 (1994) 95-100
4. Aiyar A., Tyree C., and Sugden B. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. EMBO J. 17 21 (1998) 6394-6403
5. Al-Homsi A.S., Berger C., Van Baarle D., Kersten M.J., Klein M.R., McQuain C., Van Oers R., and Knecht H. Molecular analysis of critical sequences within the EBNA-2 type 1 gene from Epstein-Barr virus isolates from patients with infectious mononucleosis, tonsillar hyperplasia, and HIV infection. Int. J. Mol. Med. 1 6 (1998) 983-987
6. Apolloni A., and Sculley T.B. Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes. Virology 202 2 (1994) 978-981
7. Ayadi W., Feki L., Khabir A., Boudawara T., Ghorbel A., Charfeddine I., Daoud J., Frikha M., Hammami A., and Karray-Hakim H. Polymorphism analysis of Epstein-Barr virus isolates of nasopharyngeal carcinoma biopsies from Tunisian patients. Virus Genes 34 2 (2007) 137-145
8. Baer R., Bankier A.T., Biggin M.D., Deininger P.L., Farrell P.J., Gibson T.J., Hatfull G., Hudson G.S., Satchwell S.C., Seguin C., et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310 5974 (1984) 207-211
9. Barozzi P., Luppi M., Cagossi K., Maiorana A., Marasca R., Artusi T., Poggi S., Pileri S.A., and Torelli G. The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign. Ann. Oncol. 10 4 (1999) 467-469
10. Bell M.J., Brennan R., Miles J.J., Moss D.J., Burrows J.M., and Burrows S.R. Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response. J. Infect. Dis. 197 11 (2008) 1594-1597
11. Berger C., Rothenberger S., Bachmann E., McQuain C., Nadal D., and Knecht H. Sequence polymorphisms between latent membrane proteins LMP1 and LMP2A do not correlate in EBV-associated reactive and malignant lympho-proliferations. Int. J. Cancer 81 3 (1999) 371-375
12. Bhatia K., Raj A., Guitierrez M.I., Judde J.G., Spangler G., Venkatesh H., and Magrath I.T. Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene 13 1 (1996) 177-181
13. Bouzid M., Djennaoui D., Dubreuil J., Bouguermouh A., Ellouz D., Abdelwahab J., Decaussin G., and Ooka T. Epstein-Barr virus genotypes in NPC biopsies from north Africa. Int. J. Cancer 56 4 (1994) 468-473
14. Bouzid M., Sheng W., Buisson M., Bouguermouh A., Morand P., Seigneurin J.M., and Ooka T. Different distribution of H1-H2 Epstein-Barr virus variant in oropharyngeal virus and in biopsies of Hodgkin's disease and in nasopharyngeal carcinoma from Algeria. Int. J. Cancer 77 2 (1998) 205-210
15. Brady G., Macarthur G.J., and Farrell P.J. Epstein-Barr virus and Burkitt lymphoma. Postgrad. Med. J. 84 993 (2008) 372-377
16. Bray F., Haugen M., Moger T.A., Tretli S., Aalen O.O., and Grotmol T. Age-incidence curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications. Cancer Epidemiol. Biomarkers Prev. 17 9 (2008) 2356-2365
17. Burrows J.M., Khanna R., Sculley T.B., Alpers M.P., Moss D.J., and Burrows S.R. Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequences. J. Virol. 70 7 (1996) 4829-4833
18. Carbone A. Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol. 4 1 (2003) 22-29
19. Carbone A., Gloghini A., Serraino D., and Spina M. HIV-associated Hodgkin lymphoma. Curr. Opin. HIV AIDS 4 1 (2009) 3-10
20. Cardy A.H., Sharp L., and Little J. Burkitt's lymphoma: a review of the epidemiology. Kuwait Med. J. 33 4 (2001) 293-306
21. Chan J.K., Tsang W.Y., Ng C.S., Wong C.S., and Lo E.S. A study of the association of Epstein-Barr virus with Burkitt's lymphoma occurring in a Chinese population. Histopathology 26 3 (1995) 239-245
22. Chang E.T., and Adami H.O. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol. Biomarkers Prev. 15 10 (2006) 1765-1777
23. Chang K.L., Chen Y.Y., Chen W.G., Hayashi K., Bacchi C., Bacchi M., and Weiss L.M. EBNA-1 gene sequences in Brazilian and American patients with Hodgkin's disease. Blood 94 1 (1999) 244-250
24. Chang K.P., Hao S.P., Lin S.Y., Ueng S.H., Pai P.C., Tseng C.K., Hsueh C., Hsieh M.S., Yu J.S., and Tsang N.M. The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma. Laryngoscope 116 4 (2006) 541-546
25. Chang Y.S., Su I.J., Chung P.J., Shu C.H., Ng C.K., Wu S.J., and Liu S.T. Detection of an Epstein-Barr-virus variant in T-cell-lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population. Int. J. Cancer 62 6 (1995) 673-677
26. Chen H.L., Lung M.L., Chan K.H., Griffin B.E., and Ng M.H. Tissue distribution of Epstein-Barr virus genotypes. J. Virol. 70 10 (1996) 7301-7305
27. Chen W.G., Chen Y.Y., Bacchi M.M., Bacchi C.E., Alvarenga M., and Weiss L.M. Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Type A with a high prevalence of deletions within the latent membrane protein gene. Am. J. Pathol. 148 1 (1996) 17-23
28. Cheung S.T., Leung S.F., Lo K.W., Chiu K.W., Tam J.S., Fok T.F., Johnson P.J., Lee J.C., and Huang D.P. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. Int. J. Cancer 76 3 (1998) 399-406
29. Cheung S.T., Lo K.W., Leung S.F., Chan W.Y., Choi P.H., Johnson P.J., Lee J.C., and Huang D.P. Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. Int. J. Cancer 66 5 (1996) 711-712
30. Chiang A.K., Wong K.Y., Liang A.C., and Srivastava G. Comparative analysis of Epstein-Barr virus gene polymorphisms in nasal T/NK-cell lymphomas and normal nasal tissues: implications on virus strain selection in malignancy. Int. J. Cancer 80 3 (1999) 356-364
31. Cohen J.I. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases. Semin. Hematol. 40 2 (2003) 116-123
32. Cohen J.I. Clinical aspects of Epstein-Barr virus infections. In: Robertson E.S. (Ed). Epstein-Barr Virus (2005), Caister Academic Press, Norfolk 35-54
33. Cohen J.I., Wang F., and Kieff E. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J. Virol. 65 5 (1991) 2545-2554
34. Correa R.M., Fellner M.D., Alonio L.V., Durand K., Teyssie A.R., and Picconi M.A. Epstein-Barr virus (EBV) in healthy carriers: distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene. J. Med. Virol. 73 4 (2004) 583-588
35. Countryman J., and Miller G. Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc. Natl. Acad. Sci. U.S.A. 82 12 (1985) 4085-4089
36. D'Addario M., and Chauvin P. Ethnic differences in the expression of Epstein-Barr virus latent membrane protein-1 mutations in nasopharyngeal carcinoma. Mutat. Res. 457 1-2 (2000) 69-78
37. Dambaugh T., Hennessy K., Chamnankit L., and Kieff E. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc. Natl. Acad. Sci. U.S.A. 81 23 (1984) 7632-7636
38. Delecluse H.J., Feederle R., O'Sullivan B., and Taniere P. Epstein Barr virus-associated tumours: an update for the attention of the working pathologist. J. Clin. Pathol. 60 12 (2007) 1358-1364
39. Dinand V., and Arya L.S. Epidemiology of childhood Hodgkins disease: is it different in developing countries?. Indian Pediatr. 43 2 (2006) 141-147
40. Do N.V., Ingemar E., Phi P.T., Jenny A., Chinh T.T., Zeng Y., and Hu L. A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8. Virus Res. 132 1-2 (2008) 15-24
41. Dolcetti R., Zancai P., De Re V., Gloghini A., Bigoni B., Pivetta B., De Vita S., Carbone A., and Boiocchi M. Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease. Blood 89 5 (1997) 1723-1731
42. Edwards R.H., Seillier-Moiseiwitsch F., and Raab-Traub N. Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains. Virology 261 1 (1999) 79-95
43. Edwards R.H., Sitki-Green D., Moore D.T., and Raab-Traub N. Potential selection of LMP1 variants in nasopharyngeal carcinoma. J. Virol. 78 2 (2004) 868-881
44. Farrell P.J. Epstein-Barr virus genome. In: Robertson E.S. (Ed). Epstein-Barr Virus (2005), Caister Academic Press, Norfolk 263-288
45. Fassone L., Cingolani A., Martini M., Migliaretti G., Oreste P.L., Capello D., Gloghini A., Vivenza D., Dolcetti R., Carbone A., Antinori A., Gaidano G., and Larocca L.M. Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma. AIDS Res. Hum. Retroviruses 18 1 (2002) 19-26
46. Fennewald S., van Santen V., and Kieff E. Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J. Virol. 51 2 (1984) 411-419
47. Ferlay J., Bray F., Pisani P., and Parkin D.M. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase, 5 (2004), IARCPress, Lyon
48. Goldschmidts W.L., Bhatia K., Johnson J.F., Akar N., Gutierrez M.I., Shibata D., Carolan M., Levine A., and Magrath I.T. Epstein-Barr virus genotypes in AIDS-associated lymphomas are similar to those in endemic Burkitt's lymphomas. Leukemia 6 9 (1992) 875-878
49. Gorzer I., Niesters H.G., Cornelissen J.J., and Puchhammer-Stockl E. Characterization of Epstein-Barr virus type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes. Virus Res. 118 1-2 (2006) 105-114
50. Gratama J.W., and Ernberg I. Molecular epidemiology of Epstein-Barr virus infection. Adv. Cancer Res. 67 (1995) 197-255
51. Gratama J.W., Oosterveer M.A., Klein G., and Ernberg I. EBNA size polymorphism can be used to trace Epstein-Barr virus spread within families. J. Virol. 64 10 (1990) 4703-4708
52. Grunewald V., Bonnet M., Boutin S., Yip T., Louzir H., Levrero M., Seigneurin J.M., Raphael M., Touitou R., Martel-Renoir D., Cochet C., Durandy A., Andre P., Lau W., Zeng Y., and Joab I. Amino-acid change in the Epstein-Barr-virus ZEBRA protein in undifferentiated nasopharyngeal carcinomas from Europe and North Africa. Int. J. Cancer 75 4 (1998) 497-503
53. Guiretti D.M., Chabay P.A., Valva P., Stefanoff C.G., Barros M.H., De Matteo E., Renault I.Z., Preciado M.V., and Hassan R. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas. J. Med. Virol. 79 11 (2007) 1730-1822
54. Gutierrez M.I., Bhatia K., Barriga F., Diez B., Muriel F.S., de Andreas M.L., Epelman S., Risueno C., and Magrath I.T. Molecular epidemiology of Burkitt's lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions. Blood 79 12 (1992) 3261-3266
55. Gutierrez M.I., Ibrahim M.M., Dale J.K., Greiner T.C., Straus S.E., and Bhatia K. Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus. J. Natl. Cancer Inst. 94 23 (2002) 1757-1763
56. Gutierrez M.I., Kingma D.W., Sorbara L., Tran M., Raffeld M., Jaffe E.S., Magrath I., and Bhatia K. Association of EBV strains, defined by multiple loci analyses, in non-Hodgkin lymphomas and reactive tissues from HIV positive and HIV negative patients. Leuk. Lymphoma 37 3-4 (2000) 425-429
57. Gutierrez M.I., Raj A., Spangler G., Sharma A., Hussain A., Judde J.G., Tsao S.W., Yuen P.W., Joab I., Magrath I.T., and Bhatia K. Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells. J. Gen. Virol. 78 Pt 7 (1997) 1663-1670
58. Habeshaw G., Yao Q.Y., Bell A.I., Morton D., and Rickinson A.B. Epstein-Barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas. J. Virol. 73 2 (1999) 965-975
59. Harrington D.S., Weisenburger D.D., and Purtilo D.T. Epstein-Barr virus-associated lymphoproliferative lesions. Clin. Lab. Med. 8 1 (1988) 97-118
60. Hatzivassiliou E., and Mosialos G. Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1. Front. Biosci. 7 (2002) d319-d329
61. Hayashi K., Chen W.G., Chen Y.Y., Bacchi M.M., Bacchi C.E., Alvarenga M., Abreu E.S., Chang K.L., and Weiss L.M. Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: high frequency of a 30-bp deletion. Hum. Pathol. 28 12 (1997) 1408-1414
62. Henry S., Sacaze C., Berrajah L., Karray H., Drira M., Hammami A., Icart J., and Mariame B. In nasopharyngeal carcinoma-bearing patients, tumors and lymphocytes are infected by different Epstein-Barr virus strains. Int. J. Cancer 91 5 (2001) 698-704
63. Higa M., Kinjo T., Kamiyama K., Iwamasa T., Hamada T., and Iyama K. Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan. J. Clin. Pathol. 55 6 (2002) 414-423
64. Hsu J.L., and Glaser S.L. Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit. Rev. Oncol. Hematol. 34 1 (2000) 27-53
65. Hu L.F., Zabarovsky E.R., Chen F., Cao S.L., Ernberg I., Klein G., and Winberg G. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J. Gen. Virol. 72 Pt 10 (1991) 2399-2409
66. IARC, 1997. Epstein-Barr Virus and Kaposi's csvirus, vol. 8. IARC, Lyon, p. 70.
67. Itakura O., Yamada S., Narita M., and Kikuta H. High prevalence of a 30-base pair deletion and single-base mutations within the carboxy terminal end of the LMP-1 oncogene of Epstein-Barr virus in the Japanese population. Oncogene 13 7 (1996) 1549-1553
68. Izumi K.M., and Kieff E.D. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB. Proc. Natl. Acad. Sci. U.S.A. 94 23 (1997) 12592-12597
69. Jenkins P.J., and Farrell P.J. Are particular Epstein-Barr virus strains linked to disease?. Semin. Cancer Biol. 7 4 (1996) 209-215
70. Jeon Y.K., Lee B.Y., Kim J.E., Lee S.S., and Kim C.W. Molecular characterization of Epstein-Barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea. Head Neck 26 7 (2004) 573-583
71. Ji K.M., Li C.L., Meng G., Han A.D., and Wu X.L. New BZLF1 sequence variations in EBV-associated undifferentiated nasopharyngeal carcinoma in southern China. Arch. Virol. 153 10 (2008) 1949-1953
72. Joab I., Nicolas J.C., Schwaab G., de-The G., Clausse B., Perricaudet M., and Zeng Y. Detection of anti-Epstein-Barr-virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int. J. Cancer 48 5 (1991) 647-649
73. Kelly G., Bell A., and Rickinson A. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nat. Med. 8 10 (2002) 1098-1104
74. Kelly G.L., Milner A.E., Tierney R.J., Croom-Carter D.S., Altmann M., Hammerschmidt W., Bell A.I., and Rickinson A.B. Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis. J. Virol. 79 16 (2005) 10709-10717
75. Kempkes B. EBNA-2 and notch signalling. In: Robertson E.S. (Ed). Epstein-Barr Virus (2005), Caister Academic Press, Norfolk 463-500
76. Khanim F., Yao Q.Y., Niedobitek G., Sihota S., Rickinson A.B., and Young L.S. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 88 9 (1996) 3491-3501
77. Kim S.M., Kang S.H., and Lee W.K. Identification of two types of naturally-occurring intertypic recombinants of Epstein-Barr virus. Mol. Cells 21 2 (2006) 302-307
78. Klemenc P., Marin J., Soba E., Gale N., Koren S., and Strojan P. Distribution of Epstein-Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma. J. Med. Virol. 78 8 (2006) 1083-1090
79. Klumb C.E., Hassan R., De Oliveira D.E., De Resende L.M., Carrico M.K., De Almeida Dobbin J., Pombo-De-Oliveira M.S., Bacchi C.E., and Maia R.C. Geographic variation in Epstein-Barr virus-associated Burkitt's lymphoma in children from Brazil. Int. J. Cancer 108 1 (2004) 66-70
80. Levitskaya J., Coram M., Levitsky V., Imreh S., Steigerwald-Mullen P.M., Klein G., Kurilla M.G., and Masucci M.G. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375 6533 (1995) 685-688
81. Lin J.C., Cherng J.M., Lin H.J., Tsang C.W., Liu Y.X., and Lee S.P. Amino acid changes in functional domains of latent membrane protein 1 of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan: prevalence of an HLA A2-restricted 'epitope-loss variant'. J. Gen. Virol. 85 Pt 7 (2004) 2023-2034
82. Lin J.C., Lin S.C., Luppi M., Torelli G., and Mar E.C. Geographic sequence variation of latent membrane protein 1 gene of Epstein-Barr virus in Hodgkin's lymphomas. J. Med. Virol. 45 2 (1995) 183-191
83. Lin S.X., Zong Y.S., Wu Q.L., Han A.J., and Liang Y.J. Loss of an XhoI-site within N-terminal region of Epstein-Barr virus LMP1 gene in nasopharyngeal carcinoma. Ai Zheng 22 11 (2003) 1147-1151
84. Lindsey J.W., Patel S., and Zou J. Epstein-Barr virus genotypes in multiple sclerosis. Acta Neurol. Scand. 117 2 (2008) 141-144
85. Lung M.L., and Chang G.C. Detection of distinct Epstein-Barr virus genotypes in NPC biopsies from southern Chinese and Caucasians. Int. J. Cancer 52 1 (1992) 34-37
86. Lung M.L., Chang G.C., Miller T.R., Wara W.M., and Phillips T.L. Genotypic analysis of Epstein-Barr virus isolates associated with nasopharyngeal carcinoma in Chinese immigrants to the United States. Int. J. Cancer 59 6 (1994) 743-746
87. Lung M.L., Chang R.S., Huang M.L., Guo H.Y., Choy D., Sham J., Tsao S.Y., Cheng P., and Ng M.H. Epstein-Barr virus genotypes associated with nasopharyngeal carcinoma in southern China. Virology 177 1 (1990) 44-53
88. Lung M.L., Lam W.P., Sham J., Choy D., Yong-Sheng Z., Guo H.Y., and Ng M.H. Detection and prevalence of the "f" variant of Epstein-Barr virus in southern China. Virology 185 1 (1991) 67-71
89. MacKenzie J., Gray D., Pinto-Paes R., Barrezueta L.F., Armstrong A.A., Alexander F.A., McGeoch D.J., and Jarrett R.F. Analysis of Epstein-Barr virus (EBV) nuclear antigen 1 subtypes in EBV-associated lymphomas from Brazil and the United Kingdom. J. Gen. Virol. 80 Pt 10 (1999) 2741-2745
90. Mainou B.A., and Raab-Traub N. LMP1 strain variants: biological and molecular properties. J. Virol. 80 13 (2006) 6458-6468
91. Martini M., Capello D., Serraino D., Navarra A., Pierconti F., Cenci T., Gaidano G., and Larocca L.M. Characterization of variants in the promoter of EBV gene BZLF1 in normal donors. HIV-positive patients and in AIDS-related lymphomas. J. Infect. 54 3 (2007) 298-306
92. Mbulaiteye S.M., Biggar R.J., Bhatia K., Linet M.S., and Devesa S.S. Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005. Pediatr. Blood Cancer (2009)
93. McGeoch D.J., and Gatherer D. Lineage structures in the genome sequences of three Epstein-Barr virus strains. Virology 359 1 (2007) 1-5
94. Midgley R.S., Blake N.W., Yao Q.Y., Croom-Carter D., Cheung S.T., Leung S.F., Chan A.T., Johnson P.J., Huang D., Rickinson A.B., and Lee S.P. Novel intertypic recombinants of Epstein-Barr virus in the Chinese population. J. Virol. 74 3 (2000) 1544-1548
95. Miller W.E., Edwards R.H., Walling D.M., and Raab-Traub N. Sequence variation in the Epstein-Barr virus latent membrane protein 1. J. Gen. Virol. 75 Pt 10 (1994) 2729-2740
96. Mueller N.E., and Grufferman S. Hodgkin lymphoma. In: Schottenfeld D., and Fraumeni J.F. (Eds). Cancer Epidemiology and Prevention (2006), Oxford University Press, Inc., New York 872-897
97. Munch M. Epstein-Barr virus strain characterization. APMIS 106 4 (1998) 425-433
98. Nagamine M., Takahara M., Kishibe K., Nagato T., Ishii H., Bandoh N., Ogino T., and Harabuchi Y. Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK/T-cell lymphoma. Virus Genes 34 1 (2007) 47-54
99. Nguyen-Van D., Ernberg I., Phan-Thi Phi P., Tran-Thi C., and Hu L. Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1. Virus Genes 37 2 (2008) 273-281
100. Packham G., Brimmell M., Cook D., Sinclair A.J., and Farrell P.J. Strain variation in Epstein-Barr virus immediate early genes. Virology 192 2 (1993) 541-550
101. Philip T. Burkitt's lymphoma in Europe. IARC Sci. Publ. 60 (1985) 107-118
102. Plaza G., Santon A., Vidal A.M., and Bellas C. Latent membrane protein-1 oncogene deletions in nasopharyngeal carcinoma in Caucasian patients. Acta Otolaryngol 123 5 (2003) 664-668
103. Purtilo D.T. Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals. Lancet 1 8163 (1980) 300-303
104. Purtilo D.T. Epstein-Barr virus: the spectrum of its manifestations in human beings. South Med. J. 80 8 (1987) 943-947
105. Rickinson A., and Kieff E. Epstein-Barr Virus. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. fifth ed. vol. 2 (2007), Lippincott Williams & Wilkins, Philadelphia 2655-2700
106. Rickinson A.B., Young L.S., and Rowe M. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J. Virol. 61 5 (1987) 1310-1317
107. Rochford R., Cannon M.J., and Moormann A.M. Endemic Burkitt's lymphoma: a polymicrobial disease?. Nat. Rev. Microbiol. 3 2 (2005) 182-187
108. Rooney C.M., Rowe D.T., Ragot T., and Farrell P.J. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. J. Virol. 63 7 (1989) 3109-3116
109. Rowe M., Lear A.L., Croom-Carter D., Davies A.H., and Rickinson A.B. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J. Virol. 66 1 (1992) 122-131
110. Sacaze C., Henry S., Icart J., and Mariame B. Tissue specific distribution of Epstein-Barr virus (EBV) BZLF1 gene variants in nasopharyngeal carcinoma (NPC) bearing patients. Virus Res. 81 1-2 (2001) 133-142
111. Saechan V., Mori A., Mitarnun W., Settheetham-Ishida W., and Ishida T. Analysis of LMP1 variants of EBV in Southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity. J. Clin. Virol. 36 2 (2006) 119-125
112. Sample J., Young L., Martin B., Chatman T., Kieff E., and Rickinson A. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J. Virol. 64 9 (1990) 4084-4092
113. Sandvej K., Gratama J.W., Munch M., Zhou X.G., Bolhuis R.L., Andresen B.S., Gregersen N., and Hamilton-Dutoit S. Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates. Blood 90 1 (1997) 323-330
114. Sandvej K., Zhou X.G., and Hamilton-Dutoit S. EBNA-1 sequence variation in Danish and Chinese EBV-associated tumours: evidence for geographical polymorphism but not for tumour-specific subtype restriction. J. Pathol. 191 2 (2000) 127-131
115. Santon A., and Bellas C. Deletions within the Epstein-Barr virus latent membrane protein-1 oncogene in adult ordinary. HIV-associated and paediatric Hodgkin's disease. Leuk. Lymphoma 40 3-4 (2001) 235-242
116. Santon A., Manzanal A.I., Campo E., and Bellas C. Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease. Clin. Mol. Pathol. 48 4 (1995) M184-M187
117. Schuster V., Ott G., Seidenspinner S., and Kreth H.W. Common Epstein-Barr virus (EBV) type-1 variant strains in both malignant and benign EBV-associated disorders. Blood 87 4 (1996) 1579-1585
118. Schuster V., Seidenspinner S., and Kreth H.W. Detection of a nuclear antigen 2 (EBNA2)-variant Epstein-Barr virus strain in two siblings with fatal lymphoproliferative disease. J. Med. Virol. 48 1 (1996) 114-120
119. See H.S., Yap Y.Y., Yip W.K., and Seow H.F. Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia. World J. Surg. Oncol. 6 (2008) 18
120. Sheng W., Bouguermouh A., Bouzid M., Djennaoui D., and Ooka T. BAMHI DNA fragment H-polymorphism of Epstein-Barr virus is associated with the mutations present in an 89 BP sequence localized in EBNA2 gene. Virus Genes 29 1 (2004) 99-108
121. Shim Y.S., Kim C.W., and Lee W.K. Sequence variation of EBNA2 of Epstein-Barr virus isolates from Korea. Mol. Cells 8 2 (1998) 226-232
122. Shimizu N., and Takada K. Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence. J. Virol. 67 6 (1993) 3240-3245
123. Shu C.H., and Tu T.Y. Prevalence of the Taiwan variant of the Epstein-Barr virus in nasopharyngeal carcinoma patients and normal individuals. Zhonghua Yi Xue Za Zhi (Taipei) 63 4 (2000) 288-293
124. Sitki-Green D., Covington M., and Raab-Traub N. Compartmentalization and transmission of multiple Epstein-Barr virus strains in asymptomatic carriers. J. Virol. 77 3 (2003) 1840-1847
125. Sitki-Green D., Edwards R.H., Webster-Cyriaque J., and Raab-Traub N. Identification of Epstein-Barr virus strain variants in hairy leukoplakia and peripheral blood by use of a heteroduplex tracking assay. J. Virol. 76 19 (2002) 9645-9656
126. Sixbey J.W., Shirley P., Chesney P.J., Buntin D.M., and Resnick L. Detection of a second widespread strain of Epstein-Barr virus. Lancet 2 8666 (1989) 761-765
127. Srivastava G., Wong K.Y., Chiang A.K., Lam K.Y., and Tao Q. Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state. Blood 95 7 (2000) 2443-2445
128. Sugden B., and Warren N. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J. Virol. 6 6 (1989) 2644-2649
129. Sung N.S., Edwards R.H., Seillier-Moiseiwitsch F., Perkins A.G., Zeng Y., and Raab-Traub N. Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China. Int. J. Cancer 76 2 (1998) 207-215
130. Tamura S., Kunimoto M., Tabata T., and Yoshie O. Genotypic analysis of Epstein-Barr virus associated with nasopharyngeal carcinoma of Japanese patients. Jpn. J. Cancer Res. 84 3 (1993) 246-249
131. Tan E.L., Peh S.C., and Sam C.K. Analyses of Epstein-Barr virus latent membrane protein-1 in Malaysian nasopharyngeal carcinoma: high prevalence of 30-bp deletion. Xho1 polymorphism and evidence of dual infections. J. Med. Virol. 69 2 (2003) 251-257
132. Tang Y.L., Lu J.H., Cao L., Wu M.H., Peng S.P., Zhou H.D., Huang C., Yang Y.X., Zhou Y.H., Chen Q., Li X.L., Zhou M., and Li G.Y. Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: potential loss of T cell epitopes. Braz. J. Med. Biol. Res. 41 2 (2008) 110-116
133. Tao Q., Robertson K.D., Manns A., Hildesheim A., and Ambinder R.F. Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. Blood 91 4 (1998) 1373-1381
134. Tao Q., Young L.S., Woodman C.B., and Murray P.G. Epstein-Barr virus (EBV) and its associated human cancers-genetics, epigenetics, pathobiology and novel therapeutics. Front. Biosci. 11 (2006) 2672-2713
135. Tedeschi R., Pin E., Martorelli D., Bidoli E., Marus A., Pratesi C., Bortolin M.T., Zanussi S., Vaccher E., Dolcetti R., and De Paoli P. Serum antibody response to lytic and latent Epstein-Barr virus antigens in undifferentiated nasopharyngeal carcinoma patients from an area of nonendemicity. Clin. Vaccine Immunol. 14 4 (2007) 435-441
136. Thompson M.P., and Kurzrock R. Epstein-Barr virus and cancer. Clin. Cancer Res. 10 3 (2004) 803-821
137. Thorley-Lawson D.A., and Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 350 13 (2004) 1328-1337
138. Tierney R.J., Edwards R.H., Sitki-Green D., Croom-Carter D., Roy S., Yao Q.Y., Raab-Traub N., and Rickinson A.B. Multiple Epstein-Barr virus strains in patients with infectious mononucleosis: comparison of ex vivo samples with in vitro isolates by use of heteroduplex tracking assays. J. Infect. Dis. 193 2 (2006) 287-297
139. Tiwawech D., Srivatanakul P., Karalak A., and Ishida T. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais. J. Clin. Virol. 42 1 (2008) 1-6
140. Tong J.H., Lo K.W., Au F.W., Huang D.P., and To K.F. Re: Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus. J. Natl. Cancer Inst. 95 13 (2003) 1008-1009 author reply 1009
141. Triantos D., Leao J.C., Porter S.R., Scully C.M., and Teo C.G. Tissue distribution of Epstein-Barr virus genotypes in hosts coinfected by HIV. AIDS 12 16 (1998) 2141-2146
142. Trimeche M., Bonnet C., Korbi S., Boniver J., and de Leval L. Association between Epstein-Barr virus and Hodgkin's lymphoma in Belgium: a pathological and virological study. Leuk. Lymphoma 48 7 (2007) 1323-1331
143. Vallat-Decouvelaere A.V., Bretel M.A., Vassias I., Laplanche J.L., Polivka M., Wassef M., Brunet M., Thiebaut J.B., Gosselin B., Morinet F., and Mikol J. High frequency of a 30-bp deletion of Epstein-Barr virus latent membrane protein 1 gene in primary HIV non-Hodgkin's brain lymphomas. Neuropathol. Appl. Neurobiol. 28 6 (2002) 471-479
144. Walling D.M., Brown A.L., Etienne W., Keitel W.A., and Ling P.D. Multiple Epstein-Barr virus infections in healthy individuals. J. Virol. 77 11 (2003) 6546-6550
145. Walling D.M., Perkins A.G., Webster-Cyriaque J., Resnick L., and Raab-Traub N. The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression. J. Virol. 68 12 (1994) 7918-7926
146. Walling D.M., Shebib N., Weaver S.C., Nichols C.M., Flaitz C.M., and Webster-Cyriaque J. The molecular epidemiology and evolution of Epstein-Barr virus: sequence variation and genetic recombination in the latent membrane protein-1 gene. J. Infect. Dis. 179 4 (1999) 763-774
147. Wang J.T., Sheeng T.S., Su I.J., Chen J.Y., and Chen M.R. EBNA-1 sequence variations reflect active EBV replication and disease status or quiescent latency in lymphocytes. J. Med. Virol. 69 3 (2003) 417-425
148. Wang W.Y., Chien Y.C., Jan J.S., Chueh C.M., and Lin J.C. Consistent sequence variation of Epstein-Barr virus nuclear antigen 1 in primary tumor and peripheral blood cells of patients with nasopharyngeal carcinoma. Clin. Cancer Res. 8 8 (2002) 2586-2590
149. Weiss L.M. Epstein-Barr virus and Hodgkin's disease. Curr. Oncol. Rep. 2 2 (2000) 199-204
150. Wu S.J., Lay J.D., Chen C.L., Chen J.Y., Liu M.Y., and Su I.J. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area. J. Med. Virol. 50 4 (1996) 314-321
151. Yao Q.Y., Tierney R.J., Croom-Carter D., Cooper G.M., Ellis C.J., Rowe M., and Rickinson A.B. Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals. J. Virol. 70 8 (1996) 4895-4903
152. Yao Q.Y., Tierney R.J., Croom-Carter D., Dukers D., Cooper G.M., Ellis C.J., Rowe M., and Rickinson A.B. Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals. J. Virol. 70 8 (1996) 4884-4894
153. Yates J., Warren N., Reisman D., and Sugden B. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. U.S.A. 81 12 (1984) 3806-3810
154. Yates J.L., Camiolo S.M., Ali S., and Ying A. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function. Virology 222 1 (1996) 1-13
155. Yoshizaki T., Miwa H., Takeshita H., Sato H., and Furukawa M. Elevation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma. J. Cancer Res. Clin. Oncol. 126 2 (2000) 69-73
156. Young L.S., Yao Q.Y., Rooney C.M., Sculley T.B., Moss D.J., Rupani H., Laux G., Bornkamm G.W., and Rickinson A.B. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J. Gen. Virol. 68 Pt 11 (1987) 2853-2862
157. Zhang X.S., Song K.H., Mai H.Q., Jia W.H., Feng B.J., Xia J.C., Zhang R.H., Huang L.X., Yu X.J., Feng Q.S., Huang P., Chen J.J., and Zeng Y.X. The 30-bp deletion variant: a polymorphism of latent membrane protein 1 prevalent in endemic and non-endemic areas of nasopharyngeal carcinomas in China. Cancer Lett. 176 1 (2002) 65-73
158. Zhang X.S., Wang H.H., Hu L.F., Li A., Zhang R.H., Mai H.Q., Xia J.C., Chen L.Z., and Zeng Y.X. V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma. Cancer Lett. 211 1 (2004) 11-18
159. Zhou X.G., Sandvej K., Li P.J., Ji X.L., Yan Q.H., Zhang X.P., Da J.P., and Hamilton-Dutoit S.J. Epstein-Barr virus gene polymorphisms in Chinese Hodgkin's disease cases and healthy donors: identification of three distinct virus variants. J. Gen. Virol. 82 Pt 5 (2001) 1157-1167
160. Zimber U., Adldinger H.K., Lenoir G.M., Vuillaume M., Knebel-Doeberitz M.V., Laux G., Desgranges C., Wittmann P., Freese U.K., Schneider U., et al. Geographical prevalence of two types of Epstein-Barr virus. Virology 154 1 (1986) 56-66